Ruti Aga: The Six-Year Ban, a Forged Prescription, and a Defence Buried Under Its Own Paperwork

The first document in my ledger for this case is a prescription nobody wrote. According to the Athletics Integrity Unit statement, Ruti Aga's family member produced it — a man with no medical registration, who claimed he had used an old prescription pad from a former workplace, and whose clinic of origin has since stated plainly that it has nothing to do with the document. Three verifications, three separate refusals.

10 September. The same date appears twice in the AIU statement: once as the start of the provisional suspension, once as the starting point for the six-year ban. Two years for the presence of methylprednisolone, four years for tampering with the investigation. Add them and you get six. In marathon terms this reads as the end of a career; in ledger terms it is the sum of two different cases with two very different evidential bases.

Every set piece leaves a ledger, and I read it after the whistle. The whistle has gone here. What remains is paperwork, not sentiment.

Who Ruti Aga is

A 32-year-old Ethiopian marathoner. She won the 2026 Tokyo Marathon, a World Marathon Major title, and that achievement does not disappear anywhere in this file. The statement also records three second-place finishes at World Marathon Majors. My own notes carry Berlin 2026 in 2:18:34 (second) and Tokyo 2026 in 2:20:40 (first), though those figures await source confirmation, so I keep them inside brackets rather than stating them as claims.

What the statement does confirm: she won a half marathon in China in March, and the sample taken there contained methylprednisolone. The time is not given. No splits, no field strength, no season's best. Any sentence about that performance would be invention. The one fact that holds is that the race was won — which implies an elite field, in-competition testing, and an AIU sample in existence.

A confession before we go further. The printed start list was the first document I trusted, and in this case I do not have one. I have a sanction sheet. When I began sending a one-page PDF before every meet in 2026, the rule was that no claim would travel without a season's best attached. This story has no season's best, so its centre is procedure, not performance.

Ethiopian women's marathon depth is essential context. There is a stack of sub-2:16 performers, world-record-class athletes, and a 2:18–2:20 runner is not automatically selectable for a national team. That matters because the sanction arithmetic that follows has zero effect on the national team and an absolute effect on the athlete.

The chemistry of the prescription, and the error repeated across reports

A technical correction is needed here, because the whole legal hinge of the case rests on it. Media reports described methylprednisolone as a prohibited steroid and said WADA classifies it as performance enhancing. That is imprecise. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List — not an anabolic steroid (S1). And S9 is prohibited in-competition only, and only by injection, oral or rectal routes.

One sentence changes the architecture of the case. The question is not whether a steroid was used. The question is by which route, at what dose, and how many hours before the race. A therapeutic knee injection given out of competition is entirely legal. The same injection still resident in the body on race day is a violation. A road race testing window opens at 23:59 the day before the race, which means an injection given days earlier can be caught. That is the foundation of the defence that existed here.

One more thing worth stating plainly: there is no solid evidence that glucocorticoids enhance endurance performance. They reduce pain and swelling and make a knee usable. That is medicine, not doping advantage. Reading six years as a steroid sentence puts the whole file on the wrong shelf.

The defence that was available, and how it died

If the knee injury was real — and intra-articular methylprednisolone for knee synovitis is standard sports medicine in distance runners — three routes were open. Apply for or hold a Therapeutic Use Exemption. Observe the correct washout period for the route used. Or arrive with genuine medical records showing treatment rather than enhancement. None of these appears in the statement.

What appears is a manufactured document. That is where the case moves from accident to offence. A true treatment gets defended with real records; a forged prescription is produced where real records do not exist.

Three verification failures are recorded at three different levels. The clinic did not exist — a documentary failure. The doctor had no registration — a professional failure. The clinic whose name was on the pad disowned the pad — an institutional failure. A document broken in three places is difficult to call a misunderstanding.

The statement also records that the tampering charge came from an interview, meaning statements made under questioning rather than a document alone. The tape is a witness, and I prefer witnesses to experts. So I stop here: until the interview transcript is public, I will not print an allegation of translation or language unfairness. Language conditions in AIU interviews with Ethiopian athletes are a recurring friction point, but recurring friction is not proof. Before the verdict, I lay the season; there is no season here, so I delay the verdict.

2 + 4 = 6, and what the arithmetic hides

Two years for the presence of methylprednisolone. That is the period normally built for a specified substance finding where intent is not established. Four years for tampering — the Code's standard sanction. Six in total.

The sum is itself information. Had the panel found no significant fault, the presence sanction could have been reduced. Six years indicates that mitigation was rejected. Read another way, the presence charge was treated without aggravating intent while the full weight fell on the tampering. There is a near-paradox here: a forged prescription is itself circumstantial evidence of concealment, yet it did not escalate the presence sanction. The panel kept the two in separate compartments.

Backdating to 10 September can look like relief. It is not. Time served under provisional suspension counts against the ban; that is procedural benefit, not a reduction.

The age arithmetic is the harshest line in the file. Six years from 32 means a return at roughly 38. In Ethiopian women's marathon depth, a 38-year-old with a doping record on file is effectively unselectable. In legal language this is six years; in sporting language it is the end of a career. And the paperwork did that, not the substance.

The road from the knee to the pad

If I look for a single real cause in this case, it is not methylprednisolone. It is the knee. The statement cites injury as the reason for treatment, and that is where the story begins. Chronic knee pathology is a known load-bearing failure in marathoners. Heavy mileage, multiple races a year, and appearance-fee deadlines create hard pressure to mask pain.

I want to look at the other side too. I covered the era when Indian athletics had only Railways, Services and PSU jobs as professional structure; athlete security ran through appointment orders and departmental leave, and medical support often rested on informal contacts rather than formal paperwork. East African road racing runs a different model — agents, camps, race calendars, no departments. But one thing is identical in both: when an athlete has no credentialed team physician, medicine moves into informal hands, and informal hands start producing documents.

Here the doctor was a family member with no registration. That is the signature of an athlete operating without a credentialed team physician. The TUE framework exists precisely so that the line between treatment and doping is drawn by an institution rather than by an athlete's pocket.

The most worrying part is that the knee problem is likely years old rather than a single March event. A person who fabricates one document has often taken informal routes before. That is inference, not a finding, and I leave it labelled as inference.

What survives

The violation is anchored to a race in March. Absent a finding of earlier use, results before that date are not automatically annulled. The 2026 Tokyo title and three Major second places remain on the record of a genuinely elite marathoner. The disqualification scope is not stated in the statement and I will not fill it with guesswork. My reading is that the March result and its prize money are very likely voided, since that is standard AIU practice, but let the reasoned decision confirm it.

What is certain is the commercial side. Distance-running sponsorship is thin to begin with; a doping file makes it thinner. A Major podium record on one page, six years on the other. Both are true and both sit in the same ledger.

The habit of saying steroid

Word choice matters here because it is a matter of comparison, not vocabulary. Call a glucocorticoid a steroid in print and the reader compares it to anabolic cases where muscle-building and systematic concealment are at issue. Two different things get placed on the same rack. The result is that readers see the size of the sanction and assume the danger of the substance — when the sanction came from the document.

A football team with 60 per cent possession and no chances has the same lesson for sportswriting that numbers do: volume is not meaning. Six years is a large number, and large numbers hide their own reasoning. An empty stadium audits every assumption the crowd used to hide — here the crowd is the headline and the empty stadium is the AIU statement. Read the statement.

What the six years punish

Four of those years are not for the substance. Two are for the substance; four are for the prescription a family member produced and an athlete submitted. This is fundamentally a document case, not a drug case.

Three things follow. Those who frame it as harsh punishment for a minor substance are reading the wrong document — the panel applied the minimum standard sanction for the substance and put the full weight on tampering. Second, an athlete arriving with genuine records had a defence that could plausibly have ended well below two years, with no tampering charge at all. Third, and least comfortable: the moment an athlete manufactures her own defence, she converts a system failure into her own failure.

This is where I check my own habit. Load-first framing can slide into blaming the athlete for what was a calendar or federation gap. Here the athlete's fault is recorded and serious — but the structure behind it deserves a line too. The statement names the family member. It says nothing about the agent, the management, or any adviser. Who saw the document being made, who suggested submitting it, or whether it was all one person's idea is unanswered. Until it is answered, no allegation.

The competitive picture of Ethiopian women's marathon is measurably unchanged. A 32-year-old with no global championship medals leaving the selection calculus changes nothing. The real shift is on the enforcement side: AIU's road-racing focus is moving from detection to document verification. China's label-race circuit, where large appearance fees, deep East African fields and AIU testing converge, is now a high-scrutiny zone. The tier that was reliable income is also the tier that is now risk.

Who signs the next prescription

A CAS appeal window will open, typically around 21 days from the reasoned decision. An appeal is likely; overturning a document-based finding is hard. What I will watch is specific: a formal order on the March result and prize money; any investigation of the agent or management; and a statement from the Ethiopian federation, which has not been heard.

The largest question is the one I asked after every set piece in 2026: who rehearsed it? Here the rehearsal was the forged prescription. Nobody's career broke on the substance. It broke on the paper. Next time a runner with a knee injection appears on a start list, I will ask for the team physician's name before the gun. The day that question becomes routine is the day these prescriptions stop being written.